XML 22 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Net revenue $ 99,045 $ 142,566
Cost of goods sold 37,550 72,281
Gross profit 61,495 70,285
Operating expenses:    
Sales and distribution 55,979 81,911
Research and development 0 4,616
General and administrative 17,339 20,220
Impairment loss on intangibles 0 39,728 [1]
Total operating expenses 73,318 146,475
Operating loss (11,823) (76,190)
Interest expense, net 949 1,421
Change in fair value of warrant liabilities (924) (2,440)
Other expense, net 61 260
Loss before income taxes (11,909) (75,431)
Benefit for income taxes (47) (867)
Net loss $ (11,862) $ (74,564)
Net loss per share, basic and diluted (in dollars per share) $ (1.68) $ (11.43)
Weighted-average number of shares outstanding, basic and diluted(*) (in shares) [2] 7,069,404 6,524,589
[1] See Note 2, Summary of Significant Accounting Policies for more information on intangibles impairments which occurred during the year ended December 31, 2023.
[2] The number of shares and per share amounts have been retroactively restated to reflect the one for twelve (1 for 12) reverse stock split, which was effective on March 22, 2024.